Guanfacine Extended-Release (GUANFACINE)
Guanfacine Extended-Release (GUANFACINE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Guanfacine Extended-Release; Generic name: GUANFACINE; Drug class: Central alpha-2 Adrenergic Agonist [EPC].
| Brand name | Guanfacine Extended-Release |
|---|---|
| Generic name | GUANFACINE |
| Drug class | Central alpha-2 Adrenergic Agonist [EPC] |
| Manufacturer | Upsher-Smith Laboratories, LLC |
| Used for | 1 INDICATIONS AND USAGE Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [ see Clinical Studies ( 14 ) ]. Guanfacine extended-release tablets are central alpha 2A -adrenergic receptor agonist indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapyand as adjunctive therapy to stimulant medications ( 1 , 14 ) . |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Recommended dose: 1 mg to 7 mg (0.05-0.12 mg/kg target weight based dose range) once daily in the morning or evening based on clinical response and tolerability ( 2.2 ) . • Begin at a dose of 1 mg once daily and adjust in increments of no more than 1 mg/week ( 2.2 ) . • Do not crush, chew or break tablets before swallowing ( 2.1 ) . • Do not administer with high-fat meals, because of increased exposure ( 2.1 ) . • Do not substitute for immediate-release guanfacine t |
| Active ingredient(s) | GUANFACINE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07a701e2-39b7-4bb1-a7c7-d9baed4ab18a |